David R. Bauer
Lawyers
Filters
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
Corvus Pharmaceuticals $34 million stock offering
We advised the underwriters on the equity offering
Biogen exchange offer
We advised the dealer managers on a debt exchange offer
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
Bolt Biotherapeutics $230 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Revolution Medicines $300 million follow-on offering
We advised the underwriters in connection with the equity offering
CureVac $450 million public offering
We advised CureVac on the equity offering
Surgalign Holdings $37.5 million follow-on offering
We advised the underwriters on the equity offering